Literature DB >> 8183227

Expanded tuberculosis surveillance and tuberculosis morbidity--United States, 1993.

.   

Abstract

Because of the resurgence of tuberculosis (TB) in the United States, in 1987 the Advisory Committee for the Elimination of Tuberculosis recommended the strengthening of TB surveillance to improve monitoring and to assist in targeting groups at risk for disease. In addition, because of outbreaks of nosocomial multidrug-resistant TB (MDR-TB) in New York and Florida during 1990-1992, in 1992, the National MDR TB Task Force recommended that drug-susceptibility testing be performed on all initial and final Mycobacterium tuberculosis isolates from each TB patient and that the results be reported to CDC. In January 1993, in conjunction with state and local health departments, CDC implemented an expanded surveillance system for TB. This report summarizes final TB surveillance data for 1993, compares findings with previous years, and provides information on expanded surveillance.

Entities:  

Mesh:

Year:  1994        PMID: 8183227

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  11 in total

1.  Effects of intraocular rifampicin on retinal ganglion cell structure: a stereological and histopathological study.

Authors:  Ozgür Cakici; Selina Aksak; Deniz Unal; Sare Sipal; Sadullah Keles; Talha Dumlu; Murat Karamese
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

Review 2.  Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.

Authors:  A D Harries; D Maher; P Nunn
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Opportunity for exposure and risk of infection: the fuel for the tuberculosis pandemic.

Authors:  H L Rieder
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

4.  Identification of factors for tuberculosis transmission via an integrated multidisciplinary approach.

Authors:  Sarah Talarico; Kashef Ijaz; Xinyu Zhang; Leonard N Mukasa; Lixin Zhang; Carl F Marrs; M Donald Cave; Joseph H Bates; Zhenhua Yang
Journal:  Tuberculosis (Edinb)       Date:  2011-03-01       Impact factor: 3.131

Review 5.  Molecular population genetic analysis of emerged bacterial pathogens: selected insights.

Authors:  J M Musser
Journal:  Emerg Infect Dis       Date:  1996 Jan-Mar       Impact factor: 6.883

6.  Tuberculosis in North Carolina: trends across two decades, 1980-1999.

Authors:  H M Salihu; E Naik; W F O'Brien; G Dagne; R Ratard; T Mason
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

7.  Tuberculosis and HIV co-infection, California, USA, 1993–2008.

Authors:  John Z Metcalfe; Travis C Porco; Janice Westenhouse; Mark Damesyn; Matt Facer; Julia Hill; Qiang Xia; James P Watt; Philip C Hopewell; Jennifer Flood
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

8.  Emerging infections: getting ahead of the curve.

Authors:  D Satcher
Journal:  Emerg Infect Dis       Date:  1995 Jan-Mar       Impact factor: 6.883

9.  Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers.

Authors:  Cenk Babayigit; Burcin Ozer; Cahit Ozer; Tacettin Inandi; Nizami Duran; Orhan Gocmen
Journal:  Med Sci Monit       Date:  2014-03-29

10.  The usefulness of interferon-gamma release assay for diagnosis of tuberculosis-related uveitis in Korea.

Authors:  Seong Joon Ahn; Ko Eun Kim; Se Joon Woo; Kyu Hyung Park
Journal:  Korean J Ophthalmol       Date:  2014-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.